
GKB Ophthalmics Downgraded to Sell Amid Mixed Financial and Technical Signals
2026-11-17 08:35:54GKB Ophthalmics Ltd has seen its investment rating downgraded from Hold to Sell, reflecting a complex interplay of deteriorating technical indicators, cautious valuation metrics, and mixed financial trends. Despite recent positive earnings growth, concerns over long-term fundamentals and technical signals have prompted a reassessment of the stock’s outlook.
Read More
GKB Ophthalmics Upgraded to Hold on Improved Technicals and Financial Performance
2026-10-20 08:33:39GKB Ophthalmics Ltd has seen its investment rating upgraded from Sell to Hold, reflecting a notable improvement in its technical indicators and financial performance. The company’s recent quarterly results, combined with a bullish shift in technical trends, have prompted analysts to revise their outlook, signalling cautious optimism for this healthcare services micro-cap.
Read More
GKB Ophthalmics Downgraded to Sell Amid Mixed Financials and Weak Technicals
2026-10-14 08:22:13GKB Ophthalmics Ltd has seen its investment rating downgraded from Hold to Sell, reflecting a combination of deteriorating technical indicators, weak long-term fundamentals, and mixed financial trends. Despite recent positive quarterly results, the company’s overall outlook has been tempered by underperformance against benchmarks and a shift in technical momentum.
Read More
GKB Ophthalmics Ltd Locks at Upper Circuit With 10% Gain — Buyers Queue, Sellers Absent
2026-09-22 12:00:08At Rs 76.02, the buying was done — not because demand dried up, but because the exchange wouldn't let the stock go any higher. GKB Ophthalmics Ltd locked at its upper circuit of 10% on 22 Sep 2026, with buyers queuing and no sellers willing to part with shares.
Read More
GKB Ophthalmics Ltd Locks at Upper Circuit With 8.6% Gain — Buyers Queue, Sellers Absent
2026-08-31 12:00:08At Rs 68.75, the buying was done — not because demand dried up, but because the exchange wouldn't let the stock go any higher. GKB Ophthalmics Ltd locked at its upper circuit of 10% on 31 Aug 2026, with buyers queuing and no sellers willing to part with shares.
Read MoreAnnouncement under Regulation 30 (LODR)-Newspaper Publication
14-Nov-2026 | Source : BSEPlease find attached copies of newspaper cuttings of the extract of Statement of unaudited Standalone and Consolidated financial Results for the quarter and half year ended September 302026 published in Business Standard ( English Edition) and on Pudhari (Marathi) dated November 14 2026.
Financial Results Of The Company For The Quarter And Half Year Ended September 30 2026.
12-Nov-2026 | Source : BSEEnclosed please find the unaudited Standalone and Consolidated Financial Results for the quarter and half year ended September 30 2026.
Board Meeting Outcome for Outcome Of The Board Meeting Held On November 12 2026.
12-Nov-2026 | Source : BSEThe meeting of the Board of Directors of the company was held on November 12 2026 which has inter-alia considered and took on record the Unaudited Standalone and Consolidated Financial Results of the Company for the quarter and half year ended September 30 2026.
Corporate Actions
No Upcoming Board Meetings
GKB Ophthalmics Ltd has declared 12% dividend, ex-date: 21 Sep 10
No Splits history available
No Bonus history available
No Rights history available